• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Xinidamine

CAS No. 50264-78-3

Xinidamine ( —— )

产品货号. M34738 CAS No. 50264-78-3

Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2233 有现货
10MG ¥3097 有现货
25MG ¥4371 有现货
50MG ¥5385 有现货
100MG ¥6615 有现货
200MG ¥8757 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Xinidamine
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.
  • 产品描述
    Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Others
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    50264-78-3
  • 分子量
    280.32
  • 分子式
    C17H16N2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    C(N1C=2C(C(C(O)=O)=N1)=CC=CC2)C3=C(C)C=C(C)C=C3
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Alpha 1(I) Collagen ...

    This is a peptide inhibitor of collagen fibrillar matrix assembly.

  • (-)-Dihydroguaiareti...

    Aristolone is a natural product from the leaf oil of Alpinia polyantha.

  • (2R,3S,11bS)-Dihydro...

    (2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder.